Resultados de la búsqueda 21-30 of 10228 for B cell lymphomas

  1. Linfoma - Síntomas y causas - Mayo Clinic

    Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx Testing) into the routine work-up of diffuse large B-Cell lymphoma ...

  2. Hematología - Ensayos clínicos

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  6. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  9. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  10. Oncología (médica) - Ensayos clínicos

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...